Basic Information
LncRNA/CircRNA Name | circ_0001649 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, luciferase reporter assay, other |
Sample | NSCLC tissues and cell lines (A549, H358, H1299, and H1581) |
Expression Pattern | down-regulated |
Function Description | As a result, circ_0001649 was decreased in NSCLC tissues and cells and this downregulation is correlated with advanced TNM stage, positive lymph node metastasis and unfavorable prognosis. Additionally, circ_0001649 inhibited cell growth and metastasis both in vitro and in vivo. In mechanism, circ_0001649 was identified as the sponge of miR-331-3p and miR-338-5p. Moreover, the biological functions of circ_0001649 is partly dependent on its regulation on miR-331-3p and miR-338-5p. |
Pubmed ID | 30029881 |
Year | 2018 |
Title | Circular RNA circ_0001649 Acts as a Prognostic Biomarker and Inhibits NSCLC Progression via Sponging miR-331-3p and miR-338-5p |
External Links
Links for circ_0001649 | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |